These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 19179306)

  • 21. Gadofosveset-enhanced MRI as simple surrogate parameter for real-time evaluation of the initial tumour vessel infarction by retargeted tissue factor tTF-NGR.
    Höink A; Persigehl T; Kwiecien R; Balthasar M; Mesters R; Berdel W; Heindel W; Bremer C; Schwöppe C
    Oncol Lett; 2019 Jan; 17(1):270-280. PubMed ID: 30655764
    [TBL] [Abstract][Full Text] [Related]  

  • 22. An NGR-integrated and enediyne-energized apoprotein shows CD13-targeting antitumor activity.
    Zheng YB; Shang BY; Li Y; Zhen YS
    Biomed Pharmacother; 2013 Mar; 67(2):164-71. PubMed ID: 23206754
    [TBL] [Abstract][Full Text] [Related]  

  • 23. NGR-based strategies for targeting delivery of chemotherapeutics to tumor vasculature.
    Zou M; Zhang L; Xie Y; Xu W
    Anticancer Agents Med Chem; 2012 Mar; 12(3):239-46. PubMed ID: 22263803
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Addition of an aminopeptidase N-binding sequence to human endostatin improves inhibition of ovarian carcinoma growth.
    Yokoyama Y; Ramakrishnan S
    Cancer; 2005 Jul; 104(2):321-31. PubMed ID: 15952188
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Differential binding of drugs containing the NGR motif to CD13 isoforms in tumor vessels, epithelia, and myeloid cells.
    Curnis F; Arrigoni G; Sacchi A; Fischetti L; Arap W; Pasqualini R; Corti A
    Cancer Res; 2002 Feb; 62(3):867-74. PubMed ID: 11830545
    [TBL] [Abstract][Full Text] [Related]  

  • 26. In vivo tumor targeting by a NGR-decorated micelle of a recombinant diblock copolypeptide.
    Simnick AJ; Amiram M; Liu W; Hanna G; Dewhirst MW; Kontos CD; Chilkoti A
    J Control Release; 2011 Oct; 155(2):144-51. PubMed ID: 21763734
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A CD13-targeting peptide integrated protein inhibits human liver cancer growth by killing cancer stem cells and suppressing angiogenesis.
    Zheng YB; Gong JH; Liu XJ; Li Y; Zhen YS
    Mol Carcinog; 2017 May; 56(5):1395-1404. PubMed ID: 27991698
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Targeting the vasculature of colorectal carcinoma with a fused protein of (RGD)₃-tTF.
    Huang ZJ; Zhao Y; Luo WY; You J; Li SW; Yi WC; Wang SY; Yan JH; Luo Q
    ScientificWorldJournal; 2013; 2013():637086. PubMed ID: 23861656
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Preparation of truncated tissue factor antineuropilin-1 monoclonal antibody conjugate and identification of its selective thrombosis in tumor blood vessels.
    Xu P; Zou M; Wang S; Wang L; Wang L; Luo F; Wu T; Yan J
    Anticancer Drugs; 2019 Jun; 30(5):441-450. PubMed ID: 30807552
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Modification of cyclic NGR tumor neovasculature-homing motif sequence to human plasminogen kringle 5 improves inhibition of tumor growth.
    Jiang W; Jin G; Ma D; Wang F; Fu T; Chen X; Chen X; Jia K; Marikar FM; Hua Z
    PLoS One; 2012; 7(5):e37132. PubMed ID: 22590653
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Potential therapeutic impact of CD13 expression in non-small cell lung cancer.
    Schmidt LH; Brand C; Stucke-Ring J; Schliemann C; Kessler T; Harrach S; Mohr M; Görlich D; Marra A; Hillejan L; Müller-Tidow C; Lenz G; Wardelmann E; Wiewrodt R; Berdel WE; Schwöppe C; Hartmann W
    PLoS One; 2017; 12(6):e0177146. PubMed ID: 28604784
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tumor vascular infarction: prospects and challenges.
    Jahanban-Esfahlan R; Seidi K; Zarghami N
    Int J Hematol; 2017 Mar; 105(3):244-256. PubMed ID: 28044258
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel superparamagnetic iron oxide nanoparticles for tumor embolization application: preparation, characterization and double targeting.
    Chen X; Lv H; Ye M; Wang S; Ni E; Zeng F; Cao C; Luo F; Yan J
    Int J Pharm; 2012 Apr; 426(1-2):248-255. PubMed ID: 22310463
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Virus-Inspired Gold Nanorod-Mesoporous Silica Core-Shell Nanoparticles Integrated with tTF-EG3287 for Synergetic Tumor Photothermal Therapy and Selective Therapy for Vascular Thrombosis.
    Luo X; Xie J; Zhou Z; Ma S; Wang L; Li M; Liu J; Wang P; Li Y; Luo F; Yan J
    ACS Appl Mater Interfaces; 2021 Sep; 13(37):44013-44027. PubMed ID: 34494427
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Construction of novel procoagulant protein targeting neuropilin-1 on tumour vasculature for tumour embolization therapy.
    Zou M; Samiullah M; Xu P; Wang S; He J; Wu T; Luo F; Yan J
    J Drug Target; 2019 Sep; 27(8):885-895. PubMed ID: 30628471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tumor infarction in mice by antibody-directed targeting of tissue factor to tumor vasculature.
    Huang X; Molema G; King S; Watkins L; Edgington TS; Thorpe PE
    Science; 1997 Jan; 275(5299):547-50. PubMed ID: 8999802
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RGD and NGR modified TRAIL protein exhibited potent anti-metastasis effects on TRAIL-insensitive cancer cells in vitro and in vivo.
    Wang X; Qiao X; Shang Y; Zhang S; Li Y; He H; Chen SZ
    Amino Acids; 2017 May; 49(5):931-941. PubMed ID: 28236246
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Crucial role for interferon gamma in the synergism between tumor vasculature-targeted tumor necrosis factor alpha (NGR-TNF) and doxorubicin.
    Sacchi A; Gasparri A; Curnis F; Bellone M; Corti A
    Cancer Res; 2004 Oct; 64(19):7150-5. PubMed ID: 15466213
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Multi-targeting NGR-modified liposomes recognizing glioma tumor cells and vasculogenic mimicry for improving anti-glioma therapy.
    Huang D; Zhang S; Zhong T; Ren W; Yao X; Guo Y; Duan XC; Yin YF; Zhang SS; Zhang X
    Oncotarget; 2016 Jul; 7(28):43616-43628. PubMed ID: 27283987
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Development of NGR-based anti-cancer agents for targeted therapeutics and imaging.
    Wang RE; Niu Y; Wu H; Hu Y; Cai J
    Anticancer Agents Med Chem; 2012 Jan; 12(1):76-86. PubMed ID: 22023047
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.